Statins inhibit the HMG-CoA reductase enzyme, leading to a decrease in the synthesis of cholesterol. This reduction in cholesterol can affect various cellular processes, including cell proliferation and apoptosis, which are critical in cancer development. Statins also exhibit anti-inflammatory and immunomodulatory effects, which may contribute to their potential anti-cancer properties.
